blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0241285

EP0241285 - Antibiotic A42125 and process for its production [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.04.1993
Database last updated on 11.09.2024
Most recent event   Tooltip24.04.1993No opposition filed within time limitpublished on 16.06.1993 [1993/24]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1987/42]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Hamill, Robert L.
617 Brookview Drive
Greenwood Indiana 46142 / US
02 / Kastner, Ralph Emil
243 Webb Drive
Indianapolis Indiana 46227 / US
[1987/42]
Representative(s)Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1987/42]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date87303082.909.04.1987
[1987/42]
Priority number, dateUS1986085078611.04.1986         Original published format: US 850786
[1987/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0241285
Date:14.10.1987
Language:EN
[1987/42]
Type: A3 Search report 
No.:EP0241285
Date:07.09.1988
Language:EN
[1988/36]
Type: B1 Patent specification 
No.:EP0241285
Date:24.06.1992
Language:EN
[1992/26]
Search report(s)(Supplementary) European search report - dispatched on:EP18.07.1988
ClassificationIPC:C07G11/00, C12P1/04, C12N15/00
[1987/42]
CPC:
C12P1/06 (EP,US); C12N1/00 (KR); A23K20/195 (EP,US);
A61P31/04 (EP); C12N1/205 (EP,US); C12N15/00 (KR);
C12R2001/365 (EP,US); Y10S435/872 (EP,US) (-)
Designated contracting statesBE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/11]
Former [1987/42]AT,  BE,  CH,  DE,  ES,  FR,  GB,  GR,  IT,  LI,  LU,  NL,  SE 
TitleGerman:Antibiotikum A42125 und Verfahren zu dessen Herstellung[1987/42]
English:Antibiotic A42125 and process for its production[1987/42]
French:Antibiotique A42125 et procédé pour sa fabrication[1987/42]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure15.04.1987Examination requested  [1987/42]
14.11.1990Despatch of a communication from the examining division (Time limit: M02)
18.01.1991Reply to a communication from the examining division
22.08.1991Despatch of communication of intention to grant (Approval: Yes)
06.12.1991Communication of intention to grant the patent
15.02.1992Fee for grant paid
15.02.1992Fee for publishing/printing paid
Opposition(s)25.03.1993No opposition filed within time limit [1993/24]
Fees paidRenewal fee
30.04.1989Renewal fee patent year 03
02.04.1990Renewal fee patent year 04
10.04.1991Renewal fee patent year 05
22.04.1992Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0115350  (BRISTOL MYERS CO [US]);
 [A]US4524145  (MATSON JAMES A [US])
 [A]  - TETRAHEDRON LETTERS, vol. 26, no. 34, 1985, pages 4011-4014, London, GB; D.E. NETTLETON et al.: "Isolation and structure of rebeccamycin - a new antitumor antibiotic from nocardia aerocoligenes"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.